Eloxx Pharmaceuticals

📍 Watertown, United States🗓 Founded 2013👥 22 employees💰 Last funded Apr 2021
Biotechnology Research🌐 eloxxpharma.com
Website LinkedIn
Eloxx Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company developing novel RNA-modulating drug candidates that are designed to treat rare and ultra-rare premature stop codon diseases. Premature stop codons are point mutations that disrupt protein synthesis from messenger RNA. As a consequence, patients with premature stop codon diseases have reduced or eliminated protein production from the mutation bearing allele accounting for some of the most severe phenotypes in these genetic diseases. These premature stop codons have been identified in over 1,800 rare and ultra-rare diseases. Read-through therapeutic development is focused on extending mRNA half-life and increasing protein synthesis by enabling the cytoplasmic ribosome to read through premature stop codons to produce full-length proteins. Eloxx’s lead product candidate, ELX-02, is a small molecule drug candidate designed to restore production of full-length functional proteins. ELX-02 is in the early stages of clinical development focusing on cystic fibrosis and cystinosis. ELX-02 is an investigational drug that has not been approved by any global regulatory body. Eloxx is headquartered in Waltham, MA, with R&D operations in Rehovot, Israel.
1
Total investors
0
Early stage
0
Mid stage
1
Late stage
2013
Founded

Investors

1 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
United States
1
Frequently asked questions
Who invested in Eloxx Pharmaceuticals?
Eloxx Pharmaceuticals has 1 investors on record on gritt.io and 1 late-stage investors.
When did Eloxx Pharmaceuticals last raise funding?
The most recent investment in Eloxx Pharmaceuticals recorded on gritt.io was in April 2021.
When was Eloxx Pharmaceuticals founded?
Eloxx Pharmaceuticals was founded in 2013.
What industry is Eloxx Pharmaceuticals in?
Eloxx Pharmaceuticals operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is Eloxx Pharmaceuticals based?
Eloxx Pharmaceuticals is headquartered in Watertown, United States.